Cited by 213Substance Abuse Treatment and OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates

Garfield, Joshua B B, Lubman, Dan I, Yücel, Murat·2014·Australian & New Zealand Journal of Psychiatry

Abstract

OBJECTIVE: There is growing evidence that anhedonia is a commonly experienced symptom among substance-using populations. This systematic review synthesises findings across a range of substances to address questions regarding the time course of anhedonia, how anhedonia relates to other symptoms of substance dependence and whether it is similarly prevalent across all addictive drugs. METHOD: A literature search was conducted on PubMed, PsycINFO and MEDLINE, yielding 32 studies that used self-report measures of anhedonia among participants with a history of a substance abuse, dependence or long-term daily use of addictive substances. RESULTS: Findings from these studies indicate that anhedonia (1) is elevated in samples dependent on a range of substances; (2) typically appears as a consequence of substance abuse or dependence, and diminishes with abstinence; and (3) predicts increased drug cravings and the likelihood of relapse in those attempting abstinence. CONCLUSIONS: The common experience of anhedonia in substance-dependent populations, and its relationship to relapse, emphasises the importance of developing therapeutic interventions that specifically target anhedonia in the treatment of all substance use disorders.

Integrity signals

Registry

Crossref · 10.1177/0004867413508455

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The experience of anhedonia may be a consequence of substance use.

    “Those correlations have been reproduced through several studies; research on the subject identifies, in a somewhat paradoxical way, that the experience of anhedonia may be a consequence of substance use (48).”
  • In substance use disorders, the search for stimulation through consumption of substances aims to lessen the experience of anhedonia.

    “The emotional processes observed in substance use disorders suggest that the search for stimulation through the consumption of substances would aim to lessen the experience of anhedonia, an often-reported state in this population (47, 48).”
  • Deficits in reward processing occur in major depressive disorder, substance use disorders, posttraumatic stress disorder, schizophrenia, and ADHD.

    “Deficits in reward processing are found in MDD (Admon and Pizzagalli, 2015), substance use disorders (Garfield et al., 2014; Tobler et al., 2016), posttraumatic stress disorder (PTSD) (Kalebasi et al., 2015), schizophrenia (McCarthy et al., 2016), and ADHD (van Hulst et al., 2016).”

    From The effects of early life stress on reward processing (2018) · cites this paper as Garfield et al., 2014

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Garfield, J. B. B., Lubman, D. I., & Yücel, M.
Affiliations
  • Eastern Health (AU)
  • Monash University (AU)
Venue
Australian & New Zealand Journal of Psychiatry
Published
2013-11-22
Volume
48
Issue
1
Pages
36-51
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2148297013
Cited by
213
References
61
Citations by year
2026: 17 · 2025: 27 · 2024: 11 · 2023: 22 · 2022: 11 · 2021: 18 · 2020: 58 · 2019: 13 · 2018: 14 · 2017: 3 · 2016: 12 · 2015: 6 · 2013: 1
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
  • Australian & New Zealand Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
anhedonia, substance use disorders, substance dependence, abstinence, relapse, drug craving, drugs of abuse, therapeutic interventions
MeSH terms
Humans, Substance-Related Disorders, Anhedonia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review